AbCellera | Investor Conference Presentation Deck | 14 slides — playbook

AbCellera | Investor Conference Presentation Deck | 14 slides

AbCellera · 2024-01

arc beats above · slides in the middle · loops below · scroll → 0 LOOPS

Deck intelligence map

1

coverage by narrative range · generated from this deck JSON

Narrative range 14 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Whole deck 14 slides 100% 14/14 slides 100% 14/14 slides · 67 hits

— 0/14 slides

21.4% 3/14 slides 7.1% 1/14 slides

— 0/14 slides

— 0/14 slides

Slide inventory

14

every slide · same image gating as the playbook

01

front_matter

Open slide detail

02

other

Open slide detail

03

summarize

Open slide detail

04

The graphic is a stylized geometric representation of an engine or platform.present_solution

Open slide detail

05

The slide uses a split-layout with a thesis statement on the left and key metrics on the right.summarize

Open slide detail

06

Includes logos of partners: Lilly, AbbVie, Regeneron, Novartis, Incyte, Abdera Therapeutics, Empirico, Prelude Therapeutics.summarize

Open slide detail

07

The slide uses a timeline-like bar to indicate the current development stage (IND-enabling) for two specific molecules.summarize

Open slide detail

08

The slide uses a structured table to present key drug development metrics.summarize

Open slide detail

09

summarize

Open slide detail

10

The slide uses a two-column layout to present the value proposition of the platform.present_solution

Open slide detail

11

The slide demonstrates a therapeutic window improvement by comparing efficacy (killing) vs safety (cytokine release) across concentration gradients.present_solution

Open slide detail

12

The slide uses a comparative experimental design to show that AbCellera molecules (red) perform similarly or better than a reference molecule (black) in killingillustrate_case

Open slide detail

13

summarize

Open slide detail

14

summarize

Open slide detail